<table>
<tr>
<th>T Category</th>
<th>T Criteria</th>
</tr>
<tr>
<td>TX</td>
<td>Primary tumor cannot be assessed</td>
</tr>
<tr>
<td>TO</td>
<td>No tumor identified, but EBV-positive cervical node(s) involvement</td>
</tr>
<tr>
<td>Tis</td>
<td>Tumor in situ</td>
</tr>
<tr>
<td>T1</td>
<td>Tumor confined to nasopharynx, or extension to oropharynx and/or nasal cavity without parapharyngeal involvement</td>
</tr>
<tr>
<td>T2</td>
<td>Tumor with extension to parapharyngeal space, and/or adjacent soft tissue involvement (medial pterygoid, lateral pterygoid, prevertebral muscles)</td>
</tr>
<tr>
<td>T3</td>
<td>Tumor with infiltration of bony structures at skull base, cervical vertebra, pterygoid structures, and/or paranasal sinuses</td>
</tr>
<tr>
<td>T4</td>
<td>Tumor with intracranial extension, involvement of cranial nerves, hypopharynx, orbit, parotid gland, and/ or extensive soft tissue infiltration beyond the lateral surface of the lateral pterygoid muscle</td>
</tr>
</table><table>
<tr>
<th>N Category</th>
<th>N Criteria</th>
</tr>
<tr>
<td>NX</td>
<td>Regional lymph nodes cannot be assessed</td>
</tr>
<tr>
<td>NO</td>
<td>No regional lymph node metastasis</td>
</tr>
<tr>
<td>N1</td>
<td>Unilateral metastasis in cervical lymph node(s) and/ or unilateral or bilateral metastasis in retropharyngeal lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage</td>
</tr>
<tr>
<td>N2</td>
<td>Bilateral metastasis in cervical lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage</td>
</tr>
<tr>
<td>N3</td>
<td>Unilateral or bilateral metastasis in cervical lymph node(s), larger than 6 cm in greatest dimension, and/ or extension below the caudal border of cricoid cartilage</td>
</tr>
</table>